Theravance Biopharma, Inc. (NASDAQ: TBPH) Stock Information | RedChip

Theravance Biopharma, Inc. (NASDAQ: TBPH)


$8.8300
-0.2200 ( -1.78% ) 99.0K

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Market Data


Open


$8.8300

Previous close


$9.0500

Volume


99.0K

Market cap


$431.75M

Day range


$8.6850 - $9.5450

52 week range


$7.4400 - $10.4400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 May 10, 2024
4 Insider transactions 1 May 10, 2024
4 Insider transactions 1 May 10, 2024
4 Insider transactions 1 May 10, 2024
4 Insider transactions 1 May 10, 2024
4 Insider transactions 1 May 10, 2024
8-k 8K-related 13 May 09, 2024
4 Insider transactions 1 May 03, 2024
def Proxies and info statements 7 Apr 05, 2024
4 Insider transactions 1 Apr 04, 2024

Latest News